Status:
COMPLETED
Effect of Camel Milk on Chronic Hepatitis C
Lead Sponsor:
Mashhad University of Medical Sciences
Conditions:
Chronic Hepatitis C
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
Camel milk as the new modality for treatment of chronic hepatitis C. The purpose of this study is to evaluate effectiveness and safety of camel milk in combination with Peginterferon Alfa-2a and Ribav...
Detailed Description
The investigators enrolled 40 patients into the study. Group 1(Intervention ) : received PEGASYS( Peginterferon ) One subcutaneous injection containing 0.5 ml solution with180 mcg per week plus COPEGU...
Eligibility Criteria
Inclusion
- HCV (hepatitis C virus ) RNA positive
- Age age groups (18 to 70 years)
Exclusion
- Ongoing pregnancy or breast feeding
- Hx of HCC(hepatocellular carcinoma )
- Hx of alcoholic liver disease
- Hx of bleeding from esophageal varices
- Hx of hemochromatosis
- Hx of autoimmune hepatitis
- Hx of Suicidal attempt
- Hx of cerebrovascular dis
- Hx of severe retinopathy
- Hx of severe psoriasis
- Hx of scleroderma
- Hx of metabolic liver disease
- Hx of SLE(systemic lupus erythematosus )
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02216045
Start Date
June 1 2014
End Date
February 1 2015
Last Update
July 29 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Traditional Medicine
Mashhad, Razavi Khorasan Province, Iran
2
Mashhad University of Medical Sciences
Mashhad, Razavi Khorasan Province, Iran